Supply of human plasma to NHS Blood and Transplant

Supply of human plasma to NHS Blood and Transplant

NHSBT is seeking a supplier of human plasma for use in children and other selected patient groups. Plasma offered to NHSBT must only be produced from donors deemed to pose a low risk of transmission of vCJD.

UK-Filton: human blood

2012/S 137-228683

Prior information notice

Supplies

Directive 2004/18/EC

Section I: Contracting authority

I.1)Name, addresses and contact point(s)

NHS Blood and Transplant
North Bristol Park
For the attention of: Hannah Evans
BS34 7QH Filton, Bristol
UNITED KINGDOM
E-mail: Hannah.evans@nhsbt.nhs.uk

Further information can be obtained from: The above mentioned contact point(s)

I.2)Type of the contracting authority

Body governed by public law
I.3)Main activity

Health
I.4)Contract award on behalf of other contracting authorities

The contracting authority is purchasing on behalf of other contracting authorities: yes

Section II.B: Object of the contract (Supplies or services)

II.1)Title attributed to the contract by the contracting authority:

Supply of human plasma.
II.2)Type of contract and place of delivery or of performance

Supplies
NHSBT locations throughout England and Noth Wales.
Other blood services including Wales, Scotland and Sothern Ireland may also use this framework (if applicable).
NUTS code UK

II.3)Information on framework agreement
II.4)Short description of nature and quantity or value of supplies or services:

NHSBT is seeking a supplier of human plasma for use in children and other selected patient groups. Plasma offered to NHSBT must only be produced from donors deemed to pose a low risk of transmission of vCJD.
Plasma will be considered in the following formats:
1) Raw plasma which may be pathogen inactivated and further processed by NHSBT into components suitable for neonatal and paediatric transfusion;
2) Plasma that has been pathogen inactivated by the supplier and which is provided to NHSBT in neonatal and paediatric sized doses. In this case some IT development may be necessary in order to provide units with appropriate NHSBT labelling. Note that NHSBT also has a requirement to provide pathogen inactivated cryoprecipitate (single and pooled units) and this requirement may be met by the provision of finished and appropriately labelled components by the supplier.
NHSBT is looking to procure in the region of 20 000 adult doses in the first year to be reviewed annually.
II.5)Common procurement vocabulary (CPV)

33141570, 33141510

II.6)Scheduled date for start of award procedures
II.7)Information about Government Procurement Agreement (GPA)
II.8)Additional information:

The Contracting Authority intends to use an eTendering system in this procurement exercise and reserves the right to use a reverse auction.

Section III: Legal, economic, financial and technical information

III.1)Conditions relating to the contract
III.1.1)Main financing conditions and payment arrangements and/or reference to the relevant provisions governing them:
III.2)Conditions for participation
III.2.1)Information about reserved contracts

Section VI: Complementary information

VI.1)Information about European Union funds
VI.2)Additional information:

Email Hannah Evans, to confirm your interest in this PIN.
VI.3)Information on general regulatory framework

VI.4)Date of dispatch of this notice:16.7.2012